Zevra Therapeutics Inc (ZVRA)

EBITDA Growth

-83.67%

Quarterly · Period ending:

ZVRA logo

ZVRA EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-83.67%
ZVRA Quarterly EBITDA YoY % (-533.21% → -83.67%)
High-resolution chart · PNG

ZVRA ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Zevra Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-83.668%
2,455.0265%
190.6208%
105.0041%
597.8434%
111.8166%
-21.4254%
-117.9762%
-582.2513%
-10.2305%
-55.7743%
-119.3569%
90.3341%
-626.307%
-236.0385%
-262.9739%
-490.0191%
81.8071%
18.1875%
-36.6802%
133.2098%
-172.409%
22.6011%
-137.3112%
135.2495%
66.0522%
-21.8398%
124.7773%
5.9705%
56.0423%
61.1662%
-65.765%
-76.8028%
-68.6576%
-7.9219%
30.2855%
50.2055%
-1,005.4448%
-0.4121%
-35.4106%
67.6623%
73.0467%
-7.2271%
-31.1972%
-960.5341%
-169.5265%
-533.2134%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.